Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1986 Jan;203(1):34–39. doi: 10.1097/00000658-198601000-00007

Hereditary spherocytosis. Recent experience and current concepts of pathophysiology.

R D Croom 3rd, C W McMillan, E P Orringer, G F Sheldon
PMCID: PMC1251036  PMID: 3942420

Abstract

Hereditary spherocytosis is a clinically heterogeneous, genetically determined red blood cell membrane disorder resulting in hemolytic anemia. A deficiency of spectrin, the largest and most abundant structural protein of the erythrocyte membrane skeleton, results in the formation of spherocytes which lack the strength, durability, and flexibility to withstand the stresses of the circulation. Clinical manifestations of the disease are primarily dependent on the severity of hemolysis, which additionally results in an increased incidence of pigment gallstones. The likelihood of cholelithiasis is directly related to patient age and is uncommon before 10 years of age. Splenectomy is indicated in virtually every patient. When the disease is diagnosed in early childhood, the risk of overwhelming postsplenectomy sepsis makes it advisable to delay splenectomy until after 6 years of age if possible. At the time of splenectomy, it is important to identify and remove any accessory spleens. If gallstones are present, cholecystectomy should be performed. Although spherocytosis persists following splenectomy, hemolysis is alleviated and clinical cure of the anemia is achieved for most patients. Patients with recessively inherited spherocytosis are exceptions. Although they are significantly benefited by splenectomy, their anemia is not completely corrected. Splenectomy reduces hemolysis in all patients and thereby decreases the risk for development of pigment gallstones. Excision of an enlarged spleen removes the danger of traumatic rupture.

Full text

PDF
34

Images in this article

37FIG. 1.
on p.37

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agre P., Casella J. F., Zinkham W. H., McMillan C., Bennett V. Partial deficiency of erythrocyte spectrin in hereditary spherocytosis. 1985 Mar 28-Apr 3Nature. 314(6009):380–383. doi: 10.1038/314380a0. [DOI] [PubMed] [Google Scholar]
  2. Agre P., Orringer E. P., Bennett V. Deficient red-cell spectrin in severe, recessively inherited spherocytosis. N Engl J Med. 1982 May 13;306(19):1155–1161. doi: 10.1056/NEJM198205133061906. [DOI] [PubMed] [Google Scholar]
  3. BATES G. C., BROWN C. H. Incidence of gallbladder disease in chronic hemolytic anemia (spherocytosis). Gastroenterology. 1952 May;21(1):104–109. [PubMed] [Google Scholar]
  4. Barker K., Martin F. R. Splenectomy in congenital microspherocytosis. Br J Surg. 1969 Aug;56(8):561–564. doi: 10.1002/bjs.1800560803. [DOI] [PubMed] [Google Scholar]
  5. Bart J. B., Appel M. F. Recurrent hemolytic anemia secondary to acessory spleens. South Med J. 1978 May;71(5):608–609. doi: 10.1097/00007611-197805000-00038. [DOI] [PubMed] [Google Scholar]
  6. CHAMBERLAIN D. The spleen and its removal. Ann R Coll Surg Engl. 1962 Jan;30:1–22. [PMC free article] [PubMed] [Google Scholar]
  7. Kies M. S., Abbott O. D., Rubin R. N. Recurrence of hemolysis in hereditary spherocytosis: a case due to leukemic infiltration of an accessory spleen. Mil Med. 1981 Jan;146(1):55–57. [PubMed] [Google Scholar]
  8. Krueger H. C., Burgert E. O., Jr Hereditary spherocytosis in 100 children. Mayo Clin Proc. 1966 Dec;41(12):821–830. [PubMed] [Google Scholar]
  9. Lawrie G. M., Ham J. M. The surgical treatment of hereditary spherocytosis. Surg Gynecol Obstet. 1974 Aug;139(2):208–210. [PubMed] [Google Scholar]
  10. Lux S., Shohet S. B. The erythrocyte membrane skeleton: biochemistry. Hosp Pract (Off Ed) 1984 Oct;19(10):77–83. doi: 10.1080/21548331.1984.11702920. [DOI] [PubMed] [Google Scholar]
  11. MACKENZIE A. E., ELLIOT D. H., EASTCOTT H. H., HUGHESJONES N. C., BARKHAN P., MOLLISON P. L. Relapse in hereditary spherocytosis with proven splenunculus. Lancet. 1962 May 26;1(7239):1102–1104. doi: 10.1016/s0140-6736(62)92084-6. [DOI] [PubMed] [Google Scholar]
  12. Olsen W. R., Beaudoin D. E. Increased incidence of accessory spleens in hematologic disease. Arch Surg. 1969 Jun;98(6):762–763. doi: 10.1001/archsurg.1969.01340120110019. [DOI] [PubMed] [Google Scholar]
  13. Palek J., Lux S. E. Red cell membrane skeletal defects in hereditary and acquired hemolytic anemias. Semin Hematol. 1983 Jul;20(3):189–224. [PubMed] [Google Scholar]
  14. Rutkow I. M. Twenty years of splenectomy for hereditary spherocytosis. Arch Surg. 1981 Mar;116(3):306–308. doi: 10.1001/archsurg.1981.01380150034008. [DOI] [PubMed] [Google Scholar]
  15. Shohet S. B., Lux S. E. The erythrocyte membrane skeleton: pathophysiology. Hosp Pract (Off Ed) 1984 Nov;19(11):89-95, 99, 103 passim. doi: 10.1080/21548331.1984.11702942. [DOI] [PubMed] [Google Scholar]
  16. Sullivan D. W., Glader B. E. Hereditary spherocytosis. Pediatr Ann. 1980 Aug;9(8):308–311. [PubMed] [Google Scholar]
  17. Weed R. I. Herediatary spherocytosis. A review. Arch Intern Med. 1975 Oct;135(10):1316–1323. doi: 10.1001/archinte.135.10.1316. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES